NCT00536783View on ClinicalTrials.gov

Schizophrenia Sensory Gating Deficit With Quetiapine

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine

Trial Locations (1)

87108

New Mexico VA Healthcare System, Albuquerque

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

New Mexico VA Healthcare System

FED